News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
806,643 Results
Type
Article (81635)
Company Profile (513)
Press Release (724495)
Multimedia
Podcasts (115)
Webinars (12)
Section
Business (218049)
Career Advice (3750)
Deals (38674)
Drug Delivery (128)
Drug Development (90371)
Employer Resources (183)
FDA (17965)
Job Trends (16681)
News (378263)
Policy (38340)
Tag
2024 BioCapital Digital (18)
2024 BioForest Digital (12)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (12)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (13)
2024 Pharm Country Digital (9)
2024 Pharm Country Standard (6)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2992)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (90)
Alliances (55166)
ALS (97)
Alzheimer's disease (1490)
Antibody-drug conjugate (ADC) (144)
Approvals (17929)
Artificial intelligence (289)
Autoimmune disease (27)
Automation (15)
Bankruptcy (388)
Best Places to Work (12520)
BIOSECURE Act (21)
Biosimilars (117)
Biotechnology (376)
Bladder cancer (67)
Brain cancer (31)
Breast cancer (284)
Cancer (2248)
Cardiovascular disease (195)
Career advice (3191)
Career pathing (33)
CAR-T (164)
Cell therapy (462)
Cervical cancer (21)
Clinical research (72790)
Collaboration (869)
Compensation (525)
Complete response letters (30)
COVID-19 (2857)
CRISPR (45)
C-suite (245)
Cystic fibrosis (107)
Data (2108)
Decentralized trials (2)
Denatured (41)
Depression (52)
Diabetes (282)
Diagnostics (6821)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (139)
Drug pricing (124)
Drug shortages (33)
Duchenne muscular dystrophy (99)
Earnings (85271)
Editorial (43)
Employer branding (23)
Employer resources (158)
Events (125071)
Executive appointments (735)
FDA (19216)
Featured Employer (62)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (779)
Gene editing (115)
Generative AI (30)
Gene therapy (338)
GLP-1 (840)
Government (5111)
Grass and pollen (5)
Guidances (51)
Healthcare (20782)
Huntington's disease (25)
IgA nephropathy (28)
Immunology and inflammation (139)
Indications (27)
Infectious disease (3016)
Inflammatory bowel disease (149)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (95)
Interviews (729)
IPO (17605)
IRA (51)
Job creations (4635)
Job search strategy (2608)
Kidney cancer (10)
Labor market (35)
Layoffs (544)
Leadership (21)
Legal (9337)
Liver cancer (78)
Lung cancer (326)
Lymphoma (144)
Machine learning (5)
Management (63)
Manufacturing (320)
MASH (70)
Medical device (14462)
Medtech (14467)
Mergers & acquisitions (21596)
Metabolic disorders (755)
Multiple sclerosis (82)
NASH (23)
Neurodegenerative disease (108)
Neuropsychiatric disorders (31)
Neuroscience (2064)
NextGen: Class of 2025 (7556)
Non-profit (5055)
Northern California (2596)
Now hiring (37)
Obesity (413)
Opinion (272)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (83)
Parkinson's disease (158)
Partnered (22)
Patents (238)
Patient recruitment (103)
Peanut (51)
People (63917)
Pharmaceutical (102)
Pharmacy benefit managers (21)
Phase I (22454)
Phase II (31621)
Phase III (23824)
Pipeline (1165)
Policy (160)
Postmarket research (3494)
Preclinical (10054)
Press Release (72)
Prostate cancer (103)
Psychedelics (38)
Radiopharmaceuticals (267)
Rare diseases (421)
Real estate (7030)
Recruiting (72)
Regulatory (26123)
Reports (43)
Research institute (2647)
Resumes & cover letters (594)
Rett syndrome (4)
RNA editing (4)
RSV (50)
Schizophrenia (77)
Series A (137)
Series B (87)
Service/supplier (15)
Sickle cell disease (58)
Southern California (2249)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (33)
Startups (4093)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (28)
The Weekly (72)
United States (23351)
Vaccines (787)
Venture capitalists (41)
Weight loss (298)
Women's health (38)
Worklife (19)
Date
Last 7 days (507)
Last 30 days (2355)
Last 365 days (35185)
2025 (9954)
2024 (37646)
2023 (42367)
2022 (53723)
2021 (58532)
2020 (57454)
2019 (51080)
2018 (38904)
2017 (36538)
2016 (37135)
2015 (43096)
2014 (37405)
2013 (33929)
2012 (35928)
2011 (36031)
2010 (35903)
Location
Africa (1187)
Alabama (59)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (48175)
Australia (8396)
California (6016)
Canada (1979)
China (524)
Colorado (269)
Connecticut (287)
Delaware (142)
Europe (110027)
Florida (889)
Georgia (209)
Idaho (63)
Illinois (598)
India (28)
Indiana (314)
Iowa (10)
Japan (154)
Kansas (106)
Kentucky (25)
Louisiana (12)
Maine (70)
Maryland (925)
Massachusetts (4653)
Michigan (242)
Minnesota (400)
Mississippi (2)
Missouri (87)
Montana (31)
Nebraska (26)
Nevada (61)
New Hampshire (69)
New Jersey (1735)
New Mexico (31)
New York (1720)
North Carolina (1074)
North Dakota (8)
Northern California (2596)
Ohio (208)
Oklahoma (15)
Oregon (39)
Pennsylvania (1341)
Puerto Rico (12)
Rhode Island (30)
South America (1559)
South Carolina (21)
South Dakota (1)
Southern California (2249)
Tennessee (100)
Texas (898)
Utah (181)
Virginia (152)
Washington D.C. (65)
Washington State (571)
West Virginia (3)
Wisconsin (62)
806,643 Results for "tufts center for the study of drug development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
December 23, 2024
·
11 min read
Press Releases
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
April 3, 2025
·
5 min read
IN PARTNERSHIP WITH SMARTLABS
How Modern Vivarium Services Are Revolutionizing Drug Development
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
March 24, 2025
·
7 min read
·
BioSpace Insights
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
BioCapital
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.
May 30, 2024
·
11 min read
Press Releases
Oligomerix Published Results from a Preclinical Therapeutic Treatment Study on an Oral Experimental Drug in Development for Alzheimer’s and Rare Neurodegenerative Diseases
March 12, 2025
·
3 min read
Legal
Jazz Settles for $145M in Anti-Trust Suits Centering on Xyrem Generics
Jazz is being accused of anti-competitive practices regarding its narcolepsy drug, as generic competitors emerge on the market.
April 9, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
April 11, 2025
·
4 min read
Policy
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
C3i Center Inc (C3i) announced it has received regulatory approval, in the form of a Drug Establishment License (DEL), to commercially produce cell therapies, making C3i the first CDMO in Canada to achieve this milestone.
June 20, 2024
·
2 min read
Press Releases
Thermo Fisher Scientific Opens Advanced Therapies Collaboration Center in Greater San Diego to Help Accelerate Cell Therapy Development
April 17, 2025
·
3 min read
1 of 80,665
Next
